Tue. Jul 27th, 2021

IEU STORE

IEU Environment Monitoring 13 July 2021 (19 pages, PDF)

SKU IEU ENVI 2021-7-13
€9.00
In stock
1
Product Details

Our IEU MONITORING headlines today:

CRITICAL RAW MATERIALS
  • EU and Ukraine kick-start strategic partnership on raw materials
  • Press remarks by Vice-President Šefčovič in Kyiv at the signing of the Partnership on Raw Materials
  • PM Denys Shmyhal on strategic EU-Ukraine partnership in the raw materials sector
  • EESC: The role of critical raw materials to form a strong industrial base
AARHUS CONVENTION
  • Aarhus Regulation: EU Commission welcomes agreement and public scrutiny of EU acts related to the environment
EU COMMISSION REGISTER
  • New EU guidance helps companies to combat forced labour in supply chains
CHEMICAL RECYCLING
  • Design for “Chemical Recycling” kills innovation upstream - Zero Waste Europe
COVID-19
  • MEPs: Boosting the EU’s capacity to anticipate and respond to health crises
  • We need to do more on the vaccine divide – Blog post by EU High Commissioner Borrell
  • S&Ds present their vaccine position paper – making the EU ready for any new pandemic is crucial
AQUACULTURE
  • EEA: Decline in ocean pH measured at the Aloha station and yearly mean surface seawater pH reported on a global scale (Copernicus Marine)
  • Governing Arctic High Seas Biodiversity - The Arctic Institute
EFSA
  • EFSA’s direction of travel set for 2022-2027
EU COMMISSION REGISTER
  • COMMISSION IMPLEMENTING DECISION amending the conditional marketing authorisation granted by Decision C(2021) 94(final) for “Spikevax - COVID-19 mRNA Vaccine (nucleoside modified)”, a medicinal product for human use
  • DÉCISION D'EXÉCUTION DE LA COMMISSION modifiant l’autorisation de mise sur le marché du médicament vétérinaire «Coxevac - Vaccin inactivé contre Coxiella burnetii» octroyée par la décision C(2010)6909
  • COMMISSION IMPLEMENTING DECISION amending the conditional marketing authorisation granted by Decision C(2020) 9598(final) for “Comirnaty - COVID-19 mRNA Vaccine (nucleoside modified)”, a medicinal product for human use
  • COMMISSION REGULATION (EU) …/… amending Annex II to Regulation (EC) No 1333/2008 of the European Parliament and of the Council and the Annex to Commission Regulation (EU) No 231/2012 as regards steviol glycosides (E 960) and rebaudioside M produced via enzyme modification of steviol glycosides from Stevia
  • COMMISSION IMPLEMENTING DECISION amending Decision 2011/891/EU and Implementing Decisions (EU) 2017/1211, (EU) 2017/1212, (EU) 2017/2449, (EU) 2019/2085 and (EU) 2019/2086 as regards the authorisation holder and its representative in the Union for the placing on the market of products containing, consisting of, or produced from certain genetically modified organisms
OSHA BRIEFS
  • Regulating telework in a post-COVID-19 Europe
EFSA BRIEFS
  • Assessment of the feed additive consisting of Lentilactobacillus buchneri (formerly Lactobacillus buchneri) DSM 16774 for all animal species for the renewal of its authorisation (Lactosan GmbH & Co.KG)
  • Peer review of the pesticide risk assessment for the active substance acibenzolar‐S‐methyl in light of confirmatory data submitted

Note

On this platform, we are publishing our IEU publications with a delay of several hours. If you want to get our monitoring e-mails in real-time you can subscribe to our full-text services on our IEU Store page. See also our FAQs for further information.

Save this product for later